Registration is now open for UCLA’s Next Generation Sequencing and Data Analysis Workshop hosted by the Clinical Microarray Core (CMC) in conjunction with the Clinical and Translational Science Institute (CTSI), the Broad Stem Cell Research Center (BSCRC), and the Department of Pathology & Laboratory Medicine at UCLA. Tute Genomics is proud to participate in this year’s event. … Continue reading UCLA Next Generation Sequencing and Data Analysis Workshop
Month: June 2015
Tute Genomics Closes Additional Series A1 Funding With Strategic Investment From Intermountain Healthcare, Healthbox, and Tencent
Investment catalyzes Tute Genomics’ efforts to enable genome-guided, individualized medicine in everyday healthcare. FOR IMMEDIATE RELEASE PROVO, Utah, June 16, 2015 – Tute Genomics, a leader in cloud-based analytics, interpretation, and reporting for clinical sequencing, today announced the closing of its Series A1 round of venture capital funding. The company raised over $3.9 million from … Continue reading Tute Genomics Closes Additional Series A1 Funding With Strategic Investment From Intermountain Healthcare, Healthbox, and Tencent
The Leah Story: Using exome sequencing to end the diagnostic odyssey for rare & undiagnosed diseases
On Wednesday, June 17th at 12:00pm ET Dr. Reid Robison, CEO of Tute Genomics delivered our inaugural Virtual Grand Rounds in Pediatric Genomic Medicine, a bi-monthly Tute Genomics webinar series where leading medical professionals will continue to present pediatric cases recently solved using next-generation sequencing technologies. ABSTRACT Significant cost reductions and rapid advancements in next-generation sequencing (NGS) … Continue reading The Leah Story: Using exome sequencing to end the diagnostic odyssey for rare & undiagnosed diseases